B. Goldin and S. Gorbach, Clinical Indications for Probiotics: An Overview, Clinical Infectious Diseases, vol.205, issue.s2, pp.96-100, 2008.
DOI : 10.1016/j.gtc.2005.05.011

URL : https://academic.oup.com/cid/article-pdf/46/Supplement_2/S96/779790/46-Supplement_2-S96.pdf

F. Shanahan, Probiotics and Inflammatory Bowel Disease: Is There a Scientific Rationale?, Inflammatory Bowel Diseases, vol.13, issue.2, pp.107-115, 2000.
DOI : 10.1097/00001574-199711000-00013

C. Surawicz, G. Elmer, P. Speelman, L. Mcfarland, and J. Chinn, Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study, Gastroenterology, vol.96, issue.4, pp.981-988, 1989.
DOI : 10.1016/0016-5085(89)91613-2

M. Guslandi, P. Giollo, and P. Testoni, A pilot trial of Saccharomyces boulardii in ulcerative colitis, European Journal of Gastroenterology & Hepatology, vol.15, issue.6, pp.697-698, 2003.
DOI : 10.1097/00042737-200306000-00017

J. Buts, D. Keyser, and N. , in rat intestinal mucosa, Scandinavian Journal of Gastroenterology, vol.60, issue.2, pp.175-185, 2010.
DOI : 10.1203/01.pdr.0000220322.31940.29

S. Jawhara and D. Poulain, in a mouse model of chemically-induced colitis, Medical Mycology, vol.6, issue.8, pp.691-700, 2007.
DOI : 10.1007/s10123-003-0132-1

A. Murzyn, A. Krasowska, D. Augustyniak, G. Majkowska-skrobek, and M. Lukaszewicz, The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407, FEMS Microbiology Letters, vol.101, issue.1, pp.17-23, 2010.
DOI : 10.1002/0471221201

A. Murzyn, A. Krasowska, P. Stefanowicz, D. Dziadkowiec, and M. Lukaszewicz, Capric Acid Secreted by S. boulardii Inhibits C. albicans Filamentous Growth, Adhesion and Biofilm Formation, PLoS ONE, vol.198, issue.8, p.12050, 2010.
DOI : 10.1371/journal.pone.0012050.s004

S. Sindhu and N. Khetarpaul, Protein and Starch Digestibilities of Indigenously Developed RWGT Food Mixture, Nutrition and Health, vol.36, issue.1, pp.173-181, 2002.
DOI : 10.1021/jf60170a046

A. Lourens-hattingh and B. Viljoen, Growth and survival of a probiotic yeast in dairy products, Food Research International, vol.34, issue.9, pp.791-796, 2001.
DOI : 10.1016/S0963-9969(01)00085-0

G. Mitterdorfer, H. Mayer, W. Kneifel, and H. Viernstein, Protein fingerprinting of Saccharomyces isolates with therapeutic relevance using one- and two-dimensional electrophoresis, PROTEOMICS, vol.2, issue.11, pp.1532-1538, 2002.
DOI : 10.1002/1615-9861(200211)2:11<1532::AID-PROT1532>3.0.CO;2-H

A. Van-der-aa-kuhle and L. Jespersen, The Taxonomic Position of Saccharomyces boulardii as Evaluated by Sequence Analysis of the D1/D2 Domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 Region and the Mitochondrial Cytochrome-c Oxidase II Gene, Systematic and Applied Microbiology, vol.26, issue.4, pp.564-571, 2003.
DOI : 10.1078/072320203770865873

F. Martins, R. Nardi, R. Arantes, C. Rosa, and M. Neves, Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice, The Journal of General and Applied Microbiology, vol.51, issue.2, pp.83-92, 2005.
DOI : 10.2323/jgam.51.83

H. Arnold, S. Micek, A. Shorr, M. Zilberberg, and A. Labelle, Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia, Pharmacotherapy, vol.30, issue.4, pp.361-368, 2010.
DOI : 10.1086/596757

C. Van-nispen-tot-pannerden, A. Verbon, and E. Kuipers, Recurrent Clostridium difficile Infection, Drugs, vol.37, issue.1, pp.853-868, 2011.
DOI : 10.1097/00004836-200307000-00012

D. Czerucka, T. Piche, and P. Rampal, Review article: yeast as probiotics -Saccharomyces boulardii, Alimentary Pharmacology & Therapeutics, vol.48, issue.Suppl. 4, Pt 2, pp.767-778, 2007.
DOI : 10.3748/wjg.v11.i39.6165

M. Guslandi, G. Mezzi, M. Sorghi, and P. Testoni, Saccharomyces boulardii in maintenance treatment of Crohn's disease, Digestive Diseases and Sciences, vol.45, issue.7, pp.1462-1464, 2000.
DOI : 10.1023/A:1005588911207

S. Thomas, D. Metzke, J. Schmitz, Y. Dorffel, and D. Baumgart, Antiinflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis, Am J Physiol Gastrointest Liver Physiol, 2011.

G. Dalmasso, F. Cottrez, V. Imbert, P. Lagadec, and J. Peyron, Saccharomyces boulardii Inhibits Inflammatory Bowel Disease by Trapping T Cells in Mesenteric Lymph Nodes, Gastroenterology, vol.131, issue.6, pp.1812-1825, 2006.
DOI : 10.1053/j.gastro.2006.10.001

G. Samonis, M. Falagas, S. Lionakis, M. Ntaoukakis, and D. Kofteridis, experimental colonization of the murine gut, Medical Mycology, vol.21, issue.4, pp.395-399, 2011.
DOI : 10.1007/s00467-006-0088-4

A. Canonici, C. Siret, E. Pellegrino, R. Pontier-bres, and L. Pouyet, Saccharomyces boulardii Improves Intestinal Cell Restitution through Activation of the ??2??1 Integrin Collagen Receptor, PLoS ONE, vol.45, issue.Pt 20, p.18427, 2011.
DOI : 10.1371/journal.pone.0018427.s002

K. Yanaba, A. Yoshizaki, Y. Asano, T. Kadono, and T. Tedder, IL-10???Producing Regulatory B10 Cells Inhibit Intestinal Injury in a Mouse Model, The American Journal of Pathology, vol.178, issue.2, 2011.
DOI : 10.1016/j.ajpath.2010.10.022

T. Zelante, D. Luca, A. Bonifazi, P. Montagnoli, C. Bozza et al., IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance, European Journal of Immunology, vol.172, issue.10, pp.2695-2706, 2007.
DOI : 10.4049/jimmunol.172.5.3059

S. Sougioultzis, S. Simeonidis, K. Bhaskar, X. Chen, and P. Anton, Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-??B-mediated IL-8 gene expression, Biochemical and Biophysical Research Communications, vol.343, issue.1, pp.69-76, 2006.
DOI : 10.1016/j.bbrc.2006.02.080

K. Reed, A. Fruin, A. Gower, K. Gonzales, and A. Stucchi, NF-??B Activation Precedes Increases in mRNA Encoding Neurokinin-1 Receptor, Proinflammatory Cytokines, and Adhesion Molecules in Dextran Sulfate Sodium???Induced Colitis in Rats, Digestive Diseases and Sciences, vol.97, issue.12, pp.2366-2378, 2005.
DOI : 10.1093/oxfordjournals.jbchem.a022634

Y. Chung, N. Walker, S. Mcginn, and K. Beauchemin, Differing effects of 2 active dried yeast (Saccharomyces cerevisiae) strains on ruminal acidosis and methane production in nonlactating dairy cows, Journal of Dairy Science, vol.94, issue.5, pp.2431-2439, 2011.
DOI : 10.3168/jds.2010-3277

J. Buts, D. Keyser, and N. , Effects of Saccharomyces boulardii on Intestinal Mucosa, Digestive Diseases and Sciences, vol.122, issue.8, pp.1485-1492, 2006.
DOI : 10.1016/0016-5085(88)90298-3

J. Lee, D. Lee, I. Ji, G. Kim, and H. Kim, Purification of Soluble ??-Glucan with Immune-enhancing Activity from the Cell Wall of Yeast, Bioscience, Biotechnology, and Biochemistry, vol.65, issue.4, pp.837-841, 2001.
DOI : 10.1271/bbb.65.837

R. Garner and J. Hudson, Intravenous injection of Candida-derived mannan results in elevated tumor necrosis factor alpha levels in serum, Infect Immun, vol.64, pp.4561-4566, 1996.

J. Chen and R. Seviour, Medicinal importance of fungal ??-(1???3), (1???6)-glucans, Mycological Research, vol.111, issue.6, pp.635-652, 2007.
DOI : 10.1016/j.mycres.2007.02.011

K. Hashimoto, Y. Okawa, K. Suzuki, Y. Okura, and S. Suzuki, Antitumor activity of acidic mannan fraction from bakers' yeast., Journal of Pharmacobio-Dynamics, vol.6, issue.9, pp.668-676, 1983.
DOI : 10.1248/bpb1978.6.668

S. Hida, N. Miura, Y. Adachi, and N. Ohno, Cell Wall ??-Glucan Derived from Candida albicans Acts as a Trigger for Autoimmune Arthritis in SKG Mice, Biological & Pharmaceutical Bulletin, vol.30, issue.8, pp.1589-1592, 2007.
DOI : 10.1248/bpb.30.1589

D. Poulain and T. Jouault, Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk, Current Opinion in Microbiology, vol.7, issue.4, pp.342-349, 2004.
DOI : 10.1016/j.mib.2004.06.011

C. Fradin, D. Poulain, and T. Jouault, beta -1,2-Linked Oligomannosides from Candida albicans Bind to a 32-Kilodalton Macrophage Membrane Protein Homologous to the Mammalian Lectin Galectin-3, Infection and Immunity, vol.68, issue.8, pp.4391-4398, 2000.
DOI : 10.1128/IAI.68.8.4391-4398.2000

S. Jawhara, X. Thuru, A. Standaert-vitse, T. Jouault, and S. Mordon, Is Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin???3, The Journal of Infectious Diseases, vol.50, issue.7, pp.972-980, 2008.
DOI : 10.1016/j.micpath.2003.06.001

URL : https://academic.oup.com/jid/article-pdf/197/7/972/18053165/197-7-972.pdf

S. Jawhara, E. Mogensen, F. Maggiotto, C. Fradin, and A. Sarazin, A murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of beta-Mannosyltransferases, J Biol Chem, 2012.

B. Thornton, V. Vetvicka, M. Pitman, R. Goldman, and G. Ross, Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18), J Immunol, vol.156, pp.1235-1246, 1996.

G. Brown and S. Gordon, Immune recognition: A new receptor for ??-glucans, Nature, vol.22, issue.6851, pp.36-37, 2001.
DOI : 10.1146/annurev.mi.22.100168.000511

G. Sener, G. Sert, O. Sehirli, A. Arbak, S. Uslu et al., Pressure ulcer-induced oxidative organ injury is ameliorated by ??-glucan treatment in rats, International Immunopharmacology, vol.6, issue.5, pp.724-732, 2006.
DOI : 10.1016/j.intimp.2005.10.010

H. Goodridge, R. Simmons, and D. Underhill, Dectin-1 Stimulation by Candida albicans Yeast or Zymosan Triggers NFAT Activation in Macrophages and Dendritic Cells, The Journal of Immunology, vol.178, issue.5, pp.3107-3115, 2007.
DOI : 10.4049/jimmunol.178.5.3107

P. Taylor, S. Tsoni, J. Willment, K. Dennehy, and M. Rosas, Dectin-1 is required for ??-glucan recognition and control of fungal infection, Nature Immunology, vol.79, issue.1, pp.31-38, 2007.
DOI : 10.1189/jlb.0605338

S. Saijo, N. Fujikado, T. Furuta, S. Chung, and H. Kotaki, Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans, Nature Immunology, vol.42, issue.1, pp.39-46, 2007.
DOI : 10.1016/S1074-7613(02)00391-6

P. Bonifazi, T. Zelante, D. Angelo, C. , D. Luca et al., Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans, Mucosal Immunology, vol.121, issue.4, pp.362-374, 2009.
DOI : 10.4049/jimmunol.180.6.4022

M. Driscoll, R. Hansen, C. Ding, D. Cramer, and Y. J. , Therapeutic potential of various ??-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy, Cancer Biology & Therapy, vol.8, issue.3, pp.218-225, 2009.
DOI : 10.4161/cbt.8.3.7337

K. Ishibashi, N. Miura, Y. Adachi, N. Ogura, and H. Tamura, Relationship between the physical properties of Candida albicans cell well ??-glucan and activation of leukocytes in vitro, International Immunopharmacology, vol.2, issue.8, pp.1109-1122, 2002.
DOI : 10.1016/S1567-5769(02)00062-0

G. Hetland, N. Ohno, I. Aaberge, and M. Lovik, Protective effect of betaglucan against systemic Streptococcus pneumoniae infection in mice, FEMS Immunol Med Microbiol, vol.27, pp.111-116, 2000.

J. Li, D. Li, J. Xing, Z. Cheng, and C. Lai, Effects of ??-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide1, Journal of Animal Science, vol.11, issue.9, pp.2374-2381, 2006.
DOI : 10.1016/0192-0561(89)90087-8

J. Liang, D. Melican, L. Cafro, G. Palace, and L. Fisette, Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity, International Journal of Immunopharmacology, vol.20, issue.11, pp.595-614, 1998.
DOI : 10.1016/S0192-0561(98)00007-1

C. Forsyth and H. Mathews, Lymphocyte Adhesion to Candida albicans, Infection and Immunity, vol.70, issue.2, pp.517-527, 2002.
DOI : 10.1128/IAI.70.2.517-527.2002

URL : http://iai.asm.org/content/70/2/517.full.pdf

V. Rousseau, J. Lepargneur, C. Roques, M. Remaud-simeon, and F. Paul, Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms, Anaerobe, vol.11, issue.3, pp.145-153, 2005.
DOI : 10.1016/j.anaerobe.2004.12.002

K. Buddington, J. Donahoo, and R. Buddington, Dietary Oligofructose and Inulin Protect Mice from Enteric and Systemic Pathogens and Tumor Inducers, The Journal of Nutrition, vol.35, issue.suppl. 222, pp.472-477, 2002.
DOI : 10.1080/10408399509527714

URL : https://academic.oup.com/jn/article-pdf/132/3/472/24016732/4w0302000472.pdf

B. Sendid, N. Dotan, S. Nseir, C. Savaux, and P. Vandewalle, Antibodies against Glucan, Chitin, and Saccharomyces cerevisiae Mannan as New Biomarkers of Candida albicans Infection That Complement Tests Based on C. albicans Mannan, Clinical and Vaccine Immunology, vol.15, issue.12, pp.1868-1877, 2008.
DOI : 10.1128/CVI.00200-08

A. Torosantucci, C. Bromuro, P. Chiani, D. Bernardis, F. Berti et al., A novel glyco-conjugate vaccine against fungal pathogens, The Journal of Experimental Medicine, vol.14, issue.5, pp.597-606, 2005.
DOI : 10.1099/00222615-27-4-233

URL : http://jem.rupress.org/content/jem/202/5/597.full.pdf

L. Hilenski, F. Naider, and J. Becker, Polyoxin D inhibits colloidal goldwheat germ agglutinin labelling of chitin in dimorphic forms of Candida albicans, J Gen Microbiol, vol.132, pp.1441-1451, 1986.

F. Martins, L. Veloso, R. Arantes, and J. Nicoli, serovar Typhimurium in mice, Letters in Applied Microbiology, vol.27, issue.6, pp.738-744, 2009.
DOI : 10.1111/j.1348-0421.2005.tb03695.x

B. Sendid, N. Francois, A. Standaert, E. Dehecq, and F. Zerimech, Prospective evaluation of the new chromogenic medium CandiSelect 4 for differentiation and presumptive identification of the major pathogenic Candida species, Journal of Medical Microbiology, vol.56, issue.4, pp.495-499, 2007.
DOI : 10.1099/jmm.0.46715-0

L. Edwards-ingram, P. Gitsham, N. Burton, G. Warhurst, and I. Clarke, Genotypic and Physiological Characterization of Saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae, Applied and Environmental Microbiology, vol.73, issue.8, pp.2458-2467, 2007.
DOI : 10.1128/AEM.02201-06

B. Siegmund, F. Rieder, S. Albrich, K. Wolf, and C. Bidlingmaier, Adenosine kinase inhibitor GP515 improves experimental colitis in mice, J Pharmacol Exp Ther, vol.296, pp.99-105, 2001.

A. Gillum, E. Tsay, and D. Kirsch, Isolation of the Candida albicans gene for orotidine-5?-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations, MGG Molecular & General Genetics, vol.180, issue.1, pp.179-182, 1984.
DOI : 10.1007/BF00328721